Cargando…

Urinary 15-F(2t)-Isoprostane Concentrations in Dogs with Liver Disease

SIMPLE SUMMARY: Similar to humans, dogs are affected by a variety of liver diseases with various causes and presentations. Recently, growing interest has focused on measuring markers of oxidative stress in patients with liver disease; however, no study to date has compared markers of oxidative stres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Robert Kyle, Steiner, Jörg M., Suchodolski, Jan S., Lidbury, Jonathan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958836/ https://www.ncbi.nlm.nih.gov/pubmed/36851386 http://dx.doi.org/10.3390/vetsci10020082

Ejemplares similares

Assessment of urinary 15‐F(2)‐isoprostanes in dogs with urothelial carcinoma of the urinary bladder and other lower urinary tract diseases
por: Woolcock, Andrew D., et al.
Publicado: (2020)

Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease
por: Lawrence, Yuri A., et al.
Publicado: (2019)

Analytical Validation of an Assay for Concurrent Measurement of Amino Acids in Dog Serum and Comparison of Amino Acid Concentrations between Whole Blood, Plasma, and Serum from Dogs
por: Blake, Amanda B., et al.
Publicado: (2022)

Proteomic analysis of liver tissue from dogs with chronic hepatitis
por: Lawrence, Yuri A., et al.
Publicado: (2018)

Serum and Fecal 3-Bromotyrosine Concentrations in Dogs with Chronic Inflammatory Enteropathy: Clinical Parameters and Histopathological Changes
por: Sattasathuchana, Panpicha, et al.
Publicado: (2023)

Serum cobalamin and methylmalonic acid concentrations in juvenile dogs with parvoviral enteritis or other acute enteropathies
por: Hung, Michael, et al.
Publicado: (2023)

Timing of Solid Food Introduction is Associated with Urinary F(2)-Isoprostane Concentrations in Childhood
por: Frederiksen, Brittni N., et al.
Publicado: (2015)

Impact of Ramadan Intermittent Fasting on Oxidative Stress Measured by Urinary 15-F(2t)-Isoprostane
por: Faris, Mo'ez Al-Islam Ezzat, et al.
Publicado: (2012)

Assessment of the Variation Associated with Repeated Measurement of Gastrointestinal Transit Times and Assessment of the Effect of Oral Ranitidine on Gastrointestinal Transit Times Using a Wireless Motility Capsule System in Dogs
por: Lidbury, Jonathan A., et al.
Publicado: (2012)

Diagnostic value of fecal cultures in dogs with chronic diarrhea
por: Werner, Melanie, et al.
Publicado: (2020)

Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019)

Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation
por: Il'yasova, Dora, et al.
Publicado: (2015)

Fecal short‐chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy
por: Minamoto, Yasushi, et al.
Publicado: (2019)

Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease
por: Blake, Amanda B., et al.
Publicado: (2019)

15‐F(2t)‐Isoprostane Concentrations and Oxidant Status in Lactating Dairy Cattle with Acute Coliform Mastitis
por: Mavangira, V., et al.
Publicado: (2016)

Randomized placebo controlled clinical trial of an enteric coated micro‐pelleted formulation of a pancreatic enzyme supplement in dogs with exocrine pancreatic insufficiency
por: Parambeth, Joseph Cyrus, et al.
Publicado: (2018)

Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies
por: Anfinsen, Kristin P, et al.
Publicado: (2014)

S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies
por: Hanifeh, Mohsen, et al.
Publicado: (2018)

Effect of oral or injectable supplementation with cobalamin in dogs with hypocobalaminemia caused by chronic enteropathy or exocrine pancreatic insufficiency
por: Chang, Chee‐Hoon, et al.
Publicado: (2022)

Evaluation of the effects of anthelmintic administration on the fecal microbiome of healthy dogs with and without subclinical Giardia spp. and Cryptosporidium canis infections
por: Fujishiro, Madeline A., et al.
Publicado: (2020)

Untargeted metabolomic profiling of serum from dogs with chronic hepatic disease
por: Lawrence, Yuri A., et al.
Publicado: (2019)

Glutathione Peroxidase Activity, Plasma Total Antioxidant Capacity, and Urinary F2‐ Isoprostanes as Markers of Oxidative Stress in Anemic Dogs
por: Kendall, A., et al.
Publicado: (2017)

Relationship of urinary isoprostanes to prostate cancer occurence
por: Brys, Magdalena, et al.
Publicado: (2012)

Stability of 3-bromotyrosine in serum and serum 3-bromotyrosine concentrations in dogs with gastrointestinal diseases
por: Sattasathuchana, Panpicha, et al.
Publicado: (2015)

Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma
por: Heilmann, Romy M., et al.
Publicado: (2017)

Long‐term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs
por: Manchester, Alison C., et al.
Publicado: (2019)

Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs
por: Xenoulis, Panagiotis G., et al.
Publicado: (2020)

The fecal microbiome and metabolome differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial diets
por: Schmidt, Milena, et al.
Publicado: (2018)

Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
por: Il'yasova, Dora, et al.
Publicado: (2012)

Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI
por: Il’yasova, Dora, et al.
Publicado: (2012)

Serum canine pancreatic-specific lipase concentrations in dogs with naturally occurring Babesia rossi infection
por: Köster, Liza S., et al.
Publicado: (2015)

Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
por: Marclay, Margaux, et al.
Publicado: (2022)

Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
por: Rivara, Matthew B., et al.
Publicado: (2015)

Effect of amoxicillin‐clavulanic acid on clinical scores, intestinal microbiome, and amoxicillin‐resistant Escherichia coli in dogs with uncomplicated acute diarrhea
por: Werner, Melanie, et al.
Publicado: (2020)

Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid‐responsive chronic inflammatory enteropathy
por: Guard, Blake C., et al.
Publicado: (2019)

Analytical validation, sample stability, and clinical evaluation of a new high-sensitivity cardiac troponin I immunoassay for use in dogs, with comparison to a previous ultrasensitive assay
por: Wesselowski, Sonya, et al.
Publicado: (2023)

Urinary F(2)‐Isoprostanes in Cats with International Renal Interest Society Stage 1–4 Chronic Kidney Disease
por: Whitehouse, W., et al.
Publicado: (2017)

The Link Between 15-F(2t)-Isoprostane Activity and Acute Bovine Endothelial Inflammation Remains Elusive
por: Putman, Ashley K., et al.
Publicado: (2022)

Long-Term Recovery of the Fecal Microbiome and Metabolome of Dogs with Steroid-Responsive Enteropathy
por: Pilla, Rachel, et al.
Publicado: (2021)

Results of histopathology, immunohistochemistry, and molecular clonality testing of small intestinal biopsy specimens from clinically healthy client‐owned cats
por: Marsilio, Sina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8laascovdd62j5r6udg71nvh8f